Abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide, with an unmet therapeutic need. Fibrotic remodeling, in which collagen-producing atrial fibroblasts play a crucial role, substantially contributes to arrhythmia promotion and progression. In this issue of the JCI, Lai, Tsai, and co-authors reveal that TGF-β1 promoted endothelial-mesenchymal transition during AF and put forward the notion that, in the adult heart, atrial fibroblasts can originate from different cellular sources. These important findings extend our understanding of the origin, biology, and function of fibroblasts and offer possibilities for therapeutic targeting of fibrosis in AF.
Original language | English |
---|---|
Article number | e161070 |
Journal | The Journal of Clinical Investigation |
Volume | 132 |
Issue number | 13 |
Number of pages | 4 |
ISSN | 0021-9738 |
DOIs | |
Publication status | Published - 2022 |
Keywords
- EXTRACELLULAR-MATRIX
- CARDIAC FIBROBLAST
- DISEASE